LATEST PSYCHEDELICS STOCKS NEWS


Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031

Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031

Havn Life Sciences to Supply Psychedelic Compounds to Clinical Studies Focused on Veterans and PTSD

Havn Life will collaborate on future clinical studies with Heroic Hearts Project to investigate effects of low-dosage psychoactive compounds on veterans the post-traumatic stress disorder (PTSD). VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"), a Canadian biotechn... Read More...

Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms

Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global supply scale of cGMP nature-sourced psilocybinDENVER, Dec. 08, 2020 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (β€œMydecine” or the β€œCompany’), an emerging biopharma and life sciences company com... Read More...

Empower Clinics Signs MOU With Simpliflying, World’s Leading Aviation Marketing Consulting Firm, to Become North American Priority COVID-19 Testing Partner for Airlines and Travel Bubbles

Empower's KAI Medical Laboratory Is A Priority Testing Partner That Is Expected To Participate In Significant Programs Aimed At Opening Up Key Travel and Hospitality IndustriesVANCOUVER, BC / ACCESSWIRE / December 8, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare co... Read More...

Codebase to Host Investor Call Featuring Arcology Blockchain Founder, Mr. Laurent Zhang

VANCOUVER, BC / ACCESSWIRE / December 7, 2020 / Codebase Ventures Inc. ("Codebase") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that Mr. Laurent Zhang, Founder of the Company's holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, will be featured in an investor call on Thursday, De... Read More...

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, Dec. 7, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and suppo... Read More...

Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham

NEW JERSEY, Dec. 07, 2020 -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has named behavioral health expert Dr. Peter Hendricks, Ph.D. to its newly formed Scientific Advisory Board.Dr. Peter Hendricks is an As... Read More...

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth

Cybin to host conference call today, December 7, 2020, at 5:00 p.m. ETTransaction adds extensive intellectual property portfolio and product pipeline to potentially diversify Cybin’s programs and includes multiple additional indications.Adelia brings a range of technologies related to novel therapeutics, delivery methods, and therapeutic ... Read More...

Silo Pharma Comments on Recent Promotional and Trading Activities at Request of OTC Markets

NEW JERSEY , Dec. 04, 2020 -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has been requested by the OTC Markets Group (β€œthe OTC Markets”) to comment on recent promotional activity.The Company became aware of certain promotional a... Read More...

Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2020) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces a strategic investment in Wonder Scientific Inc. ("Wonder Scientific").Wonder Scientific's team ... Read More...

EuroLife Brands Announces Effective Date of Name Change to Plant & Co. Brands Inc. and Increase in Private Placement

Toronto, Ontario--(Newsfile Corp. - December 3, 2020) - EuroLife Brands Inc. (CSE: EURO) (FSE: 3CMB) (OTC PINK: EURPF) ("EuroLife"), a vertically integrated enterprise focused on the health and wellness sector, is pleased to announce that it will commence trading under its new company name "Plant & Co. Brands Ltd." and ticker symbol "... Read More...

Havn Life Sciences Partners With Veterans Mental Health Non-Profit, Westwood Institute

Westwood Institute Founder, Dr. Marvin Westwood Will Work With Havn Life's Research Team to Develop Best Practices for Combining Therapy and Psychedelic Interventions for VeteransVANCOUVER, BC / ACCESSWIRE / December 3, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on un... Read More...

Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform

Expanded clinical hours being offered in response to accelerating interest from people and military veterans seeking treatment with ketamine-assisted therapy, plus launch of Portal enables enhanced experiences and greater access to therapiesTORONTO, Dec. 03, 2020 -- Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) ("Field Trip"), a leade... Read More...

Lobe Sciences Commences Engineering of Nasal Mist Device

Vancouver, British Columbia--(Newsfile Corp. - December 3, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has engaged VisionWorks Engineering of San Diego, CA to commence engineering work to complete and test a proof of concept prototype of its nasal mist device.This is a ... Read More...

Core One Labs Announces Resumption of Trading

VANCOUVER, BC / ACCESSWIRE / December 2, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABF)(FSE:LD62)(WKN:A14XHT) (the "Company") is pleased to announce that it has received approval from the Canadian Securities Exchange (the "CSE") to resume trading at the market open on Thursday, December 3, 2020 under the existing ticker symbol "COOL". ... Read More...

Betterlife Pharma Announces Closing Of $2.9 Million Private Placement Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, BC, Dec. 02, 2020 -- BetterLife Pharma Inc. (β€œBetterLife” or the β€œCompany”) (CSE: BETR) (OTCQB: BETRF) (FRA: NPAT), an emerging biotech company, is p... Read More...

Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor

TORONTO, Dec. 02, 2020 -- Revive Therapeutics Ltd. (β€œRevive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company... Read More...

Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease

Collaboration with the University of Maastricht of the NetherlandsSilo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has entered into an investigator-sponsored study agreement with Maastricht University of the Netherlands. The research... Read More...

Red Light Holland Announces Partnership with World Class Influencer & Model Khloe Terae as Clothing Brand Ambassador

Toronto, Ontario--(Newsfile Corp. - December 2, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland" or the "Company") is pleased to announce it has partnered with model and influencer, KhloΓ« Terae, who has an extensive social media following which includes 2.4 million followers on Instagram (@KhloΓ« ), ... Read More...

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

Monthly recurring revenue grows by more than 60% year over year. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./OTTAWA, ON, Nov. 17, 2020 - Martello Technologies Group Inc., ("Martello") (TSXV: M... Read More...

Empower Clinics Kai Medical Lab to Launch FDA Approved Saliva-Based COVID-19 Test December 15. Previously Announced ABC-PCR Test Launches with Film & Tv Testing Contract Increasing To 10,000 Units Commencing December 7.

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and collegesVANCOUVER, BC / ACCESSWIRE / December 2, 2020 / EMPOWER... Read More...

Mind Cure Announces Eligibility for DTC Trading

Mind Cure's common shares now able to meet US demand with more simplicityVANCOUVER, BC, Dec. 2, 2020 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("Mind Cure" or the "Company") is pleased today to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (... Read More...

Pure Extracts Collaborates with Dr. Alexander MacGregor on Cannabis and Mushroom Formulations

VANCOUVER, British Columbia, Dec. 02, 2020 -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (β€œPure Extracts” or the β€œCompany”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, is pleased to provide an introduction to Dr. Alexander MacGregor, a key scientific adv... Read More...

Nutritional High Announces Granting of Management Cease Trade Order and Amendments to Conversion Terms of Certain Debentures

Toronto, Ontario--(Newsfile Corp. - December 1, 2020) - Nutritional High International Inc. (CSE: EAT) (OTC Pink: SPLIF) ("Nutritional High" or the "Company") announces that its principal regulator, the Ontario Securities Commission (the "OSC"), has accepted the Company's request for, and has granted, a management cease trade order (the "... Read More...

Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced it has entered into a Clinical Study Agreement with the Contract Research Organization (CRO) Cen... Read More...

Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

Havn Life Has Joined the UK-Based Conservative Drug Policy Reform Group (CDPRG), Group Organized to Benefit Drug Policy-MakingThe Havn Life Advisory Board Adds Mr. King, a Vocal Advocate for Drug Policy Reform and ResearchVANCOUVER, BC / ACCESSWIRE / December 1, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Li... Read More...

Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Signed LOI for CAD$23 million sale to Ionic provides shareholder valueVancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has received and signed a non-binding letter of intent dated November 30, 2020 with IONIC Brands ... Read More...

Canbud Distribution Announces Granting of Federal Sales Licence for Medical Purposes

Toronto, Ontario--(Newsfile Corp. - December 1, 2020) - Β Canbud Distribution Corporation (CSE: CBDX) (the "Corporation") is pleased to announce that it has been granted a Federal Sales License for Medical Purposes by Health Canada.The global medical cannabis market is expected to gain market growth in the forecast period of 2020 to 2027. ... Read More...

PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform

TORONTO, Dec. 01, 2020 -- PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (β€œPharmaTher”) (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that it has amended its sponsored research agreement with Uni... Read More...

Better Plant’s Jusu Launches 8 New Juices

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") is pleased to announce the launch of eight new Jusu juices. The juices are now for sale at the Cadboro Bay Jusu Bar location at 2560B Sinclair Road in Victoria, British Col... Read More...